Brian Zeglis
Seminars
Thursday 23rd July 2026
Panel Discussion: Shaping the Future of Combination Radioligand Therapy: Preclinical Perspectives
2:30 pm
- Balancing toxicity and efficacy: minimizing radiopharmaceutical dose while enhancing tumor kill
- Timing combination therapies: strategies for preclinical-to-clinical translation
- Selecting patients using biomarkers to match optimal RLT combinations with tumor and TME characteristics
Thursday 23rd July 2026
Modulating Tumor Immunity & Resistance Mechanisms by Integrating Radioligand Therapy with Immune Checkpoint & Cellular Immunotherapies
2:00 pm
- Characterizing RLT-induced immune modulation and its role in tumor sensitization and resistance
- Evaluating preclinical combinations of RLT with immune checkpoint inhibitors, CAR-T cells, and emerging immunotherapies
- Leveraging synergistic immune-radiobiological mechanisms to enhance depth and durability of response
